FDA recall D-0164-2025

Curium US, LLC · Class II · drug

Product

Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate - 0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg. The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only, Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40

Reason for recall

Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product

Distribution

Nationwide USA and Canada.

Key facts

Status
Terminated
Initiation date
2024-11-26
Report date
2025-01-01
Termination date
2025-10-10
Voluntary/Mandated
Voluntary: Firm initiated
Location
Maryland Heights, MO, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0164-2025